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Abstracts / Osteoarthritis and Cartilage 22 (2014) S57–S489 S487Methods: Umbilical cords were dissected to obtain WJ and MC was
obtained from aw2 cm section of whole cord, which was minced into
small (w2mm2) pieces and digested in collagenase I for 1 h at 37C.
Resulting cells were cultured in DMEM-F12, 10 % FCS and Penicillin/
streptomycin. Flow cytometry, immunocytochemistry and Western
blotting was used to characterise cell markers indicative of pluripotency
(SOX2, Nanog, REX-1, OCT3/4, SSEA-3, 4, TRA-1-60, TRA-1-81 and
alkaline phosphatase) and immunogenicity (using co-stimulatory
markers, CD40, 80, 86, in addition to HLA-G, Indoleamine 2 3-dioxy-
genase and HLA-DR) before and after stimulationwith IFN-g (500 ng/ml
for 48 h). BMSC and UCMSC were cultured with allogeneic CD4þ T cells
(responder cells) (at a ratio of 1:5) labelled with violet proliferation dye
in addition to peripheral blood mononuclear cells (PBMC) (used as
stimulator cells) for 5 days. Controls were CD4þ Tcells and PBMCs alone.
After 5 days T cells were analysed via ﬂow cytometry to assess their
proliferative response.
Results: All cells showed positivity for the markers SOX2, Nanog, REX-1,
SSEA-4, Alkaline phosphatase, TRA-1-81, HLA-G and were negative for
OCT 3/4, SSEA-3 and the co-stimulatory markers CD40, CD80, CD86.
BMSC were positive for TRA-1-60, whereas UC MSC were negative.
Differences were seen between BMSC and UC MSC after stimulation
with IFN-g. UC MSC remained negative for the co-stimulatory markers
CD40, 80, 86 and HLA-DR after IFN-g stimulation, but, BMSC showed
up-regulation of HLA-DR after exposure to IFN-g. All cells were negative
for IDO before treatment with IFN-g and became positive after stim-
ulation. T cell proliferation was found to be supressed in all cultures
containing either BMSCs or UC MSCs, showing that cells from both of
these sources have immunomodulatory properties and may be capable
of dampening down immune response in vivo.
Conclusions: Umbilical cord derived MSCs may have more promise
than BMSCs as an allogeneic cell therapy as they do not produce co-
stimulatory markers or MHC (major histocompatibility complex) class II
antigens after culture in vitro in an inﬂammatory environment such as
that which may be found in an osteoarthritic joint.
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CARTILAGE ENGINEERING PROMOTES THE RECONSTRUCTION OF
HYALINE CARTILAGE
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Purpose:We previously reported that a cocktail of bonemorphogenetic
protein (BMP)-2, insulin and triiodothyronine (BIT) could trigger
redifferentiation of human chondrocytes after their ampliﬁcation on
plastic, with cartilage-characteristic matrix reconstruction when the
chondrocytes were seeded in collagen sponges (Claus et al., 2011).
However, this matrix was not homogenously distributed in the scaf-
folds, most likely because the collagen sponges were cultivated in static
conditions. With the aim of enhancing cellular access to nutrients and
the soluble factors, bi-directional ﬂow was tested to perfuse the scaf-
folds during cartilage reconstruction.
Methods: After 3 weeks of ampliﬁcation on plastic, HAC were seeded
then cultivated for 21 days in collagen sponges under bi-directional
ﬂow, by using a prototype of OPB (Oscillating Perfusion Bioreactor). We
established a program of perfusion including phases of high and low
perfusion speeds to alternate sequences of cell stimulation and matrix
deposition. For comparison, cultures of HAC in collagen sponges were
performed in static conditions. The status of the chondrocyte pheno-
type and the nature of the matrix synthesized in collagen sponges were
evaluated by real time PCR, Western Blotting and immunohistochem-
istry analyses. The viability and cell proliferation were also monitored.
Results: The results clearly indicate that perfusion improves cartilage
matrix deposition within the sponges, in comparison with static con-
ditions. More precisely, in the sponges cultured in the bioreactor,
redifferentiated and metabolically active HAC produced a cartilaginous
matrix rich in type II and type IX collagens and in glycosaminoglycans,
with no sign of hypertrophy. Interestingly, a much lower amount of type
I collagen was produced in the sponges cultivated in dynamic con-
ditions, indicating therefore that bi-directional perfusion limits the risk
of ﬁbrocartilage formation.Conclusions: The combination of HAC, collagen sponges, and the BIT
cocktail with the bi-directional perfusion bioreactor favors the recon-
struction of hyaline cartilage. Importantly, bi-directional perfusion
abolishes the spatial concentration gradients routinely observed in
scaffolds in static culture. This study also demonstrates the value of a
multi-factorial approach for the design of cell-based grafts for cartilage
repair.
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Purpose: Platelet Rich Plasma (PRP), a blood-derived product rich in
growth factors, is a promising treatment for cartilage defects in
Osteoarthritis (OA). Despite its widespread application there is a lack of
in deep studies to demonstrate its real efﬁcacy. Aim of the present study
was to investigate the effects of two different PRP preparations on
chondrocytes from osteoarthritis patients evaluating both the expres-
sion and secretion of pro-inﬂammatory and anabolic markers and the
production of some extracellular matrix proteins.
Methods: Blood from ten human volunteers was used to prepare two
different formulation of PRP: 1) Platelet Rich Plasma with a low con-
centration of platelets and leukocytes (P-PRP), 2) Platelet Rich Plasma
with a high levels of platelets and leukocytes (L-PRP). Before the
experiments, each PRP was evaluated for growth factors and cytokines
content. Chodrocytes were obtained from cartilage tissues of patients
with OA (Kellgren-Lawrence grade I-II-III) undergone surgery and were
isolated by enzymatic procedure. The cells were seeded at a high den-
sity and cultured in presence of three different concentrations (5,10 and
20%) of both P-PRP and L-PRP for 7 days. The in vitro effects of the two
different PRPs on chondrocytes were evaluated through the analysis of
cell proliferation, matrix production and expression of speciﬁc genes.
Results: Our data showed that L-PRP contains higher levels of growth
factors and cytochines compared to P-PRP. Both PRPs at all the concen-
tration evaluated stimulated chondrocyte proliferation throughout the
culture period analyzed; at day 7 P-PRP induced greater cell growth
compared with L-PRP. P-PRP stimulated chondrocyte anabolism as
demonstrated by an increased expression of collagen type II and aggre-
can, while L-PRP promoted catabolic pathways in which different cyto-
kinesare involved.However, L-PRPwasable to induceahigherexpression
of hyaluronic acid synthase-2 and hyaluronan compared to P-PRP.
Conclusions: Our study highlights some effects exerted by two differ-
ent PRP compositions on cultured human chondrocytes. These effects
are reasonably due to the content of platelets, leukocytes, growth fac-
tors and molecules which characterize each compound and that act
synergically to regulate some biological processes. The identiﬁcation of
the optimal amount and ratio of these blood components could ideally
lead to a PRP more suitable for the treatments of cartilage lesions both
of traumatic or degenerative origin.
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Purpose: We are developing the cell therapy, especially using hBMSCs,
for cartilage defect. The result of this therapy would be better if we
could get the cells, having more chondrogenic capacity, enough to tar-
get the cartilage defect. The cell-sheet would be a good candidate of the
applications to get better result. Our colleagues have reported the
Abstracts / Osteoarthritis and Cartilage 22 (2014) S57–S489S488preparation of scaffold-free cartilage-like cell-sheets derived from
hBMSCs before, that the sheets were shrunk under the serum-free
chondrogenic medium, but not under the serum mixed chondrogenic
medium. Moreover, other groups have shown the addition of basic
ﬁbroblast growth factor (bFGF) during expansion phase enhanced not
only their proliferation, but also their chondrogenic capacity of hBMSCs
with chondrogenic pellet culture system after their expansion. This
modiﬁcation during expansionphasemight be applied to the cell-sheets.
The aim of this study is to investigate better condition to provide stably
and securely the scaffold-free cartilage-like cell-sheets from hBMSCs.
Methods: The hBMSCs were harvested from bone marrow obtained by
routin iliac crest aspiration from 3 young male volunteers (21yo, 27yo,
and 31yo) with their agreement before lower extremity joint surgeries.
The proliferative and chodrogenic capacity were assessed at P1 stage.
hBMSCs were expanded with DMEM-LG containing 1% Penicillin/
Streptomycin, condition (1)5%FBS, condition (2)10%FBS, or condition (3)
5%FBS with 10ng/ml of bFGF, in monolayer culture. The proliferation
rate was determined from hemocytometer counts. Then, the cells har-
vested from the cultivation under (1), (2), and (3) were applied to v-
shaped non-adherent 96-well plate at 250,000 cells per well to perform
chondrogenic pellet culture system for 21 days. Chondrogenic differ-
entiation medium consisting of DMEM-HG with 1% ITS-premix, 10 nM
Dexamethasone,130uM ascorbate-2-phosphate,1% sodium pyruvate,1%
Penicillin/Streptomycin and 10ng/ml TGFb1 was employed for the pel-
let, and changed freshly every other day. The glycosaminoglycan (GAG)
contents of each pellet were measured and normalized with DNA (GAG/
DNA) to evaluate their chondrogenic differentiation capacity. Moreover,
the BMSCs from one donor (21yo) were expanded under the condition
(3)5%FBS with 10ng/ml of bFGF, until P3 stage to fabricate scaffold-free
cartilage-like cell-sheets with cell culture inserts (CCIs: 0.3 cm^2,
thickness, 20-25mm, polyethylene terephthalate). The sheets were
generated with condition (A) serum-free chodrogenic differentiation
medium alone or condition (B) equal mixture of serum-free chondro-
genic medium and growth medium with 10% FBS, condition(2), for 21
days. The pellets and cell-sheets were ﬁxed with 10% formalin and
embedded in parafﬁn and they were sectioned and stained with
Safranin O/Fast Green.
Results: The proliferation rates of condition(2) were 2 times higher
than (1) (p < 0.05) and (3) were 4.5 times higher than (1) (p < 0.001).
The difference between GAG/DNA of (1) and (2) was not signiﬁcant, but
that of (3) was 3 times higher than others (p< 0.05). Safranin-O staining
(3) was stained well compared (1), and (2). The cell-sheets, neither
under (A) and (B) were not shrunk nor detached from the inside wall of
CCIs, but once taken from CCIs, the sheets under (A) looked shrunk and
the edge was curling (Figure). The intensity of the Safranin-O staining
showed no difference between (A) and (B). The shape of the edge of the
(A) had curled thickening compared with (B). That of (B) was ﬂat.
Conclusion: The proliferative and chodrogenic capacity of hBMSCs
were enhanced by bFGF during expansion phase only, even if the serum
concentration was reduced. This condition might be useful to yield
much cells fast enough and to provide stably and securely the scaffold-
free cartilage-like cell-sheets.
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Purpose: Current treatment options for osteoarthritis (OA) aim to
reduce pain and improve joint functioning. However, focal cartilagedamage due to trauma predisposes the onset of OA. Use of scaffolds is a
good strategy for the treatment of these small lesions. In the past,
various synthetic and natural proteins have been described for their use
as scaffolding material for tissue engineering. However, all of these
scaffolds have advantages and disadvantages in terms of the biological
compatibility, strength, elasticity and durability of the material. The
perfect scaffolding material for articular cartilage has not been found.
We propose a new strategy for generation of cartilage scaffold material.
Many proteins and peptides can self-assemble into b-sheet rich amyloid
ﬁbrils. The resulting ﬁbrils are up to tens of nanometres wide and
several micrometres in length, and can cluster into large aggregates. As
scaffolding material, these amyloid ﬁbrils have interesting character-
istics for the generation of cartilage tissue: their mechanical properties
are comparable to collagen ﬁbres, they are degradation resistant, they
form hydrogels and can be functionalized. The purpose of this study
was to characterize amyloid ﬁbrils and to investigate the effect of
amyloid structures on bovine chondrocyte viability and metabolic
activity.
Methods: The proteins a-synuclein, b-lactoglobulin and lysozyme self-
assembled into amyloid ﬁbrils. Their formation and resulting structures
were analysed using circular dichroism, Thioﬂavin T ﬂuorescence,
atomic force microscopy (AFM) and scanning electron microscopy
(SEM). Bovine articular cartilage was collected from bovine knees and
chondrocytes were isolated from the cartilage using collagenase 2. The
bovine chondrocytes were cultured in monolayer and in the presence of
amyloid ﬁbrils or aggregates (Figure 1). The viability of the chon-
drocytes was analysed using Calcein AM in combination with ﬂow-
cytometry and the bulk metabolic activity was investigated using MTT.
Changes in gene expression, among others cartilage speciﬁc genes like
SOX9, COL2A1 and ACAN, in the presence of amyloid structures were
analysed using qPCR. In addition, the effect of the amyloid ﬁbrils on cell
viability and metabolism was investigated using different amyloid
concentrations and incubation times.
Results: SEM imaging conﬁrmed the formation of ﬁbrils. AFM imaging
conﬁrmed the formation of ﬁbrils and showed different morphologies
and heights depending on the different proteins used to form amyloid
ﬁbrils. Results indicate that the presence of a-synuclein amyloid
aggregates has no negative effects on cell viability or metabolic activity
after one week in culture. Cartilage marker gene expression went down
after culturing for one week in presence or absence of amyloid aggre-
gates, indicating that the presence of amyloid aggregates did not have
an effect on the cartilage gene speciﬁc gene expression. Finally, bovine
chondrocyte proliferation appears to increase in the presence of the
aggregates.
Conclusions: The results indicate that the different proteins can form
amyloid ﬁbrils with different morphologies and heights. In addition, a-
synuclein amyloid aggregates do not appear to inﬂuence cell viability
and cartilage gene expression. The gradual loss of articular cartilage
genes was probably due to dedifferentiation of the chondrocytes in a
monolayer culture. The effect of morphological differences between the
ﬁbrils and aggregates generated from different proteins on the cell
viability and metabolic activity will be investigated in more detail. The
